Cargando…
Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets
Calcific Aortic Valve Disease (CAVD) is the most common heart valve disease and its incidence is expected to rise with aging population. No medical treatment so far has shown slowing progression of CAVD progression. Surgery remains to this day the only way to treat it. Effective drug therapy can onl...
Autores principales: | Hulin, Alexia, Hego, Alexandre, Lancellotti, Patrizio, Oury, Cécile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862098/ https://www.ncbi.nlm.nih.gov/pubmed/29594151 http://dx.doi.org/10.3389/fcvm.2018.00021 |
Ejemplares similares
-
Prosthetic Aortic Valves: Challenges and Solutions
por: Musumeci, Lucia, et al.
Publicado: (2018) -
Editorial: From Biology to Clinical Management: An Update on Aortic Valve Disease
por: Oury, Cécile, et al.
Publicado: (2019) -
Can Blood Biomarkers Help Predicting Outcome in Transcatheter Aortic Valve Implantation?
por: Oury, Cécile, et al.
Publicado: (2018) -
Differential Biological Effects of Dietary Lipids and Irradiation on the Aorta, Aortic Valve, and the Mitral Valve
por: Donis, Nathalie, et al.
Publicado: (2022) -
Predicting Disease Progression and Mortality in Aortic Stenosis: A Systematic Review of Imaging Biomarkers and Meta-Analysis
por: Nchimi, Alain, et al.
Publicado: (2018)